Live: Can Intel Continue Its Meteoric 327% Run With Q2 Earnings Tonight?

Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

670 Articles

Chris Lange | Oct 23, 2019 at 10:25 AM EDT

Eli Lilly Just Couldn’t Get It Together in Q3

Eli Lilly shares retreated after it released mixed third-quarter financial results before the markets opened on Wednesday.

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Jon C. Ogg | Oct 17, 2019 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences,…

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 3, 2019 at 12:10 PM EDT

Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study

Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th…

Lee Jackson | Sep 27, 2019 at 10:45 AM EDT

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 9, 2019 at 12:00 PM EDT

Surprising Reaction to Lung Cancer Study Results

Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of…

Jon C. Ogg | Sep 5, 2019 at 2:00 PM EDT

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

NextCure appears to be one of those companies that has flown under the radar of the investing community since its…

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 13, 2019 at 11:00 AM EDT

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the…

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 25, 2019 at 8:35 AM EDT

Short Sellers Up the Ante in Big Pharma

The July 15 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 17 18 19 20 21 … 45

Eli Lilly : LLY

All Eli Lilly Articles

Eli Lilly Just Couldn’t Get It Together in Q3

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Big Pharma Sees Rising Tide in Short Interest

Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Short Sellers Grow More Selective in Big Pharma

Short Sellers Can’t Make Up Their Minds on Big Pharma

Surprising Reaction to Lung Cancer Study Results

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

Big Pharma Sees a Rising Tide in Short Interest

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Short Sellers Up the Ante in Big Pharma

Live: Can Intel Continue Its Meteoric 327% Run With Q2 Earnings Tonight?

Live: Will Decker Brands Beat Q1 Earnings Tonight After the Market Closes?

The Next AI Winners May Not Be the Magnificent Seven: 3 Mid-Cap ETFs to Watch

The “Hire Your Kid” Rule: Pay Your Child $15,000 From the Family Business and Neither of You Owes the IRS a Dime

You Turn 73 and the IRS Makes You Take the Money. These 3 ETFs Turn Forced RMDs Into a Paycheck

The "Hire Your Kid" Rule: Pay Your Child $15,000 From the Family Business and Neither of You Owes the IRS a Dime

5 Countries Where $500,000 Retires Better Than $1 Million Does in Florida

The Next AI Winners May Not Be the Magnificent Seven: 3 Mid-Cap ETFs to Watch

The “Hire Your Kid” Rule: Pay Your Child $15,000 From the Family Business and Neither of You Owes the IRS a Dime

Eli Lilly : LLY

All Eli Lilly Articles

Eli Lilly Just Couldn’t Get It Together in Q3

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Big Pharma Sees Rising Tide in Short Interest

Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Short Sellers Grow More Selective in Big Pharma

Short Sellers Can’t Make Up Their Minds on Big Pharma

Surprising Reaction to Lung Cancer Study Results

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

Big Pharma Sees a Rising Tide in Short Interest

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Short Sellers Up the Ante in Big Pharma

Live: Can Intel Continue Its Meteoric 327% Run With Q2 Earnings Tonight?

Live: Will Decker Brands Beat Q1 Earnings Tonight After the Market Closes?

The Next AI Winners May Not Be the Magnificent Seven: 3 Mid-Cap ETFs to Watch

The “Hire Your Kid” Rule: Pay Your Child $15,000 From the Family Business and Neither of You Owes the IRS a Dime

You Turn 73 and the IRS Makes You Take the Money. These 3 ETFs Turn Forced RMDs Into a Paycheck

Featured Reads

The "Hire Your Kid" Rule: Pay Your Child $15,000 From the Family Business and Neither of You Owes the IRS a Dime

5 Countries Where $500,000 Retires Better Than $1 Million Does in Florida